AU2003300175A8 - Hcmv derived immunomodulatory polypeptide - Google Patents
Hcmv derived immunomodulatory polypeptideInfo
- Publication number
- AU2003300175A8 AU2003300175A8 AU2003300175A AU2003300175A AU2003300175A8 AU 2003300175 A8 AU2003300175 A8 AU 2003300175A8 AU 2003300175 A AU2003300175 A AU 2003300175A AU 2003300175 A AU2003300175 A AU 2003300175A AU 2003300175 A8 AU2003300175 A8 AU 2003300175A8
- Authority
- AU
- Australia
- Prior art keywords
- hcmv
- immunomodulatory polypeptide
- derived immunomodulatory
- derived
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/16011—Herpesviridae
- C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
- C12N2710/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0223375.7 | 2002-10-09 | ||
GB0223375A GB0223375D0 (en) | 2002-10-09 | 2002-10-09 | Immunomodulatory polypeptide |
GB0303367A GB0303367D0 (en) | 2003-02-14 | 2003-02-14 | Immunomodulatory polypeptide |
GB0303367.7 | 2003-02-14 | ||
PCT/GB2003/004389 WO2004033490A2 (en) | 2002-10-09 | 2003-10-08 | Hcmv derived immunomodulatory polypeptide |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2003300175A8 true AU2003300175A8 (en) | 2004-05-04 |
AU2003300175A1 AU2003300175A1 (en) | 2004-05-04 |
Family
ID=32095189
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003300175A Abandoned AU2003300175A1 (en) | 2002-10-09 | 2003-10-08 | Hcmv derived immunomodulatory polypeptide |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003300175A1 (en) |
WO (1) | WO2004033490A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007038316A2 (en) * | 2005-09-23 | 2007-04-05 | The Trustees Of Princeton University | Human cytomegalovirus latency promoting genes, related virus variants and methods of use |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5721354A (en) * | 1995-03-31 | 1998-02-24 | Aviron | Human cytomegalovirus DNA sequences |
-
2003
- 2003-10-08 AU AU2003300175A patent/AU2003300175A1/en not_active Abandoned
- 2003-10-08 WO PCT/GB2003/004389 patent/WO2004033490A2/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2004033490A2 (en) | 2004-04-22 |
AU2003300175A1 (en) | 2004-05-04 |
WO2004033490A3 (en) | 2004-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB0208331D0 (en) | Proteins | |
GB0209884D0 (en) | Proteins | |
AU2003290563A8 (en) | Leptin-related peptides | |
GB0201679D0 (en) | Polypeptide variants | |
GB0218977D0 (en) | Polypeptide | |
EP1487874A4 (en) | Falp proteins | |
GB0212067D0 (en) | Proteins | |
AU2003300175A8 (en) | Hcmv derived immunomodulatory polypeptide | |
GB0223193D0 (en) | Polypeptide | |
GB0202275D0 (en) | Peptide | |
GB0208925D0 (en) | Polypeptide | |
GB0223375D0 (en) | Immunomodulatory polypeptide | |
AU2003270055A8 (en) | Neurotransmission-associated proteins | |
EP1477559A4 (en) | Novel polypeptide | |
GB0206684D0 (en) | Novel proteins | |
AU2003300785A8 (en) | Carbohydrate-associated proteins | |
GB0303367D0 (en) | Immunomodulatory polypeptide | |
GB0219980D0 (en) | Peptides | |
GB0202221D0 (en) | Novel polypeptide | |
GB0219720D0 (en) | Polypeptide | |
GB0222181D0 (en) | Polypeptide | |
GB0214543D0 (en) | Proteins | |
GB0216757D0 (en) | Proteins | |
AU2003295760A8 (en) | Organelle-associated proteins | |
GB0203669D0 (en) | Peptides |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |